Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 27:2020:4028635.
doi: 10.1155/2020/4028635. eCollection 2020.

The Roles of AMPK in Revascularization

Affiliations
Review

The Roles of AMPK in Revascularization

Ming-Hong Chen et al. Cardiol Res Pract. .

Abstract

Coronary heart disease (CHD) is the most common and serious illness in the world and has been researched for many years. However, there are still no real effective ways to prevent and save patients with this disease. When patients present with myocardial infarction, the most important step is to recover ischemic prefusion, which usually is accomplished by coronary artery bypass surgery, coronary artery intervention (PCI), or coronary artery bypass grafting (CABG). These are invasive procedures, and patients with extensive lesions cannot tolerate surgery. It is, therefore, extremely urgent to search for a noninvasive way to save ischemic myocardium. After suffering from ischemia, cardiac or skeletal muscle can partly recover blood flow through angiogenesis (de novo capillary) induced by hypoxia, arteriogenesis, or collateral growth (opening and remodeling of arterioles) triggered by dramatical increase of fluid shear stress (FSS). Evidence has shown that both of them are regulated by various crossed pathways, such as hypoxia-related pathways, cellular metabolism remodeling, inflammatory cells invasion and infiltration, or hemodynamical changes within the vascular wall, but still they do not find effective target for regulating revascularization at present. 5'-Adenosine monophosphate-activated protein kinase (AMPK), as a kinase, is not only an energy modulator but also a sensor of cellular oxygen-reduction substances, and many researches have suggested that AMPK plays an essential role in revascularization but the mechanism is not completely understood. Usually, AMPK can be activated by ADP or AMP, upstream kinases or other cytokines, and pharmacological agents, and then it phosphorylates key molecules that are involved in energy metabolism, autophagy, anti-inflammation, oxidative stress, and aging process to keep cellular homeostasis and finally keeps cell normal activity and function. This review makes a summary on the subunits, activation and downstream targets of AMPK, the mechanism of revascularization, the effects of AMPK in endothelial cells, angiogenesis, and arteriogenesis along with some prospects.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
The structure of AMPK subunits: AMPK have three subunits, including α, β, γ. α is catalytic while β and γ are regulatory. Both α1 and α2 subunits have a crucial site in Thr183 and Thr172, whose phosphorylation is necessary for AMPK maximal activation. The β subunits could act as a scaffold, which makes the AMPK complex located on lysosomes, an exception from having phosphorylation, myristoylation, and carbohydrate-binding sites. The γ subunits bind the nucleotides by three sites, which are the structural basis for this energy sensor.
Figure 2
Figure 2
The roles of AMPK in revascularization. After vessels are occluded, remote tissues suffer ischemia and hypoxia, the blood perfusion of collateral arterioles increases, and the FSS is elevated. FSS and hypoxia activate AMPK by different or the same ways.

References

    1. Sipahi I., Akay M. H., Dagdelen S., Blitz A., Alhan C. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease. JAMA Internal Medicine. 2014;174(2):223–230. doi: 10.1001/jamainternmed.2013.12844. - DOI - PubMed
    1. Silvestre J.-S., Smadja D. M., Lévy B. I. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiological Reviews. 2013;93(4):1743–1802. doi: 10.1152/physrev.00006.2013. - DOI - PubMed
    1. Eelen G., de Zeeuw P., Treps L., Harjes U., Wong B. W., Carmeliet P. Endothelial cell metabolism. Physiological Reviews. 2018;98(1):3–58. doi: 10.1152/physrev.00001.2017. - DOI - PMC - PubMed
    1. Draoui N., de Zeeuw P., Carmeliet P. Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism. Open Biology. 2017;7(12) doi: 10.1098/rsob.170219. - DOI - PMC - PubMed
    1. De Bock K., Georgiadou M., Carmeliet P. Role of endothelial cell metabolism in vessel sprouting. Cell Metabolism. 2013;18(18):634–647. doi: 10.1016/j.cmet.2013.08.001. - DOI - PubMed

LinkOut - more resources